Long-term health-related quality-of-life and symptom response profiles with arformoterol in COPD: results from a 52-week trial

Long-term health-related quality-of-life and symptom response profiles with arformoterol in COPD: results from a 52-week trial

James F Donohue,1 Vamsi K Bollu,2 Donald E Stull,3 Lauren M Nelson,4 Valerie SL Williams,4 Michael D Stensland,5 Nicola A Hanania6 1Department of Pulmonary Diseases and Critical Care Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, 2Worldwide Health Economics and Outcomes...

Full description

Bibliographic Details
Main Authors: Donohue JF, Bollu VK, Stull DE, Nelson LM, Williams VSL, Stensland MD, Hanania NA
Format: Article
Language:English
Published: Dove Medical Press 2018-02-01
Series:International Journal of COPD
Subjects:
St. George’s Respiratory Questionnaire
growth mixture model
HRQoL
long-acting beta agonist
Online Access:https://www.dovepress.com/long-term-health-related-quality-of-life-and-symptom-response-profiles-peer-reviewed-article-COPD

Internet

https://www.dovepress.com/long-term-health-related-quality-of-life-and-symptom-response-profiles-peer-reviewed-article-COPD

Similar Items